» Articles » PMID: 16534890

Value of Mink Vomit Model in Study of Anti-emetic Drugs

Overview
Specialty Gastroenterology
Date 2006 Mar 15
PMID 16534890
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To establish a new, reliable vomit model of minks.

Methods: Adult male minks were randomly divided into 8 groups (n=6): cisplatin (7.5 mg/kg) intraperitoneal injection (i.p.) group, copper sulfate (40 mg/kg) intragastric injection (i.g.) group, apomorphine (1.6 mg/kg) subcutaneous injection (s.c.) group, and 18 Gy whole-body X-irradiation group, ondansetron injection group (2 mg/kg i.p.) 30 min later followed by cisplatin (7.5 mg/kg) i.p., normal saline (NS) i.p. injection control group, metoclopramide injection group (4 mg/kg i.p.) 30 min later followed by apomorphine (1.6 mg/kg) s.c., NS i.g. control group. The frequency of retching and vomiting was calculated. After behavioral experiment, distribution of 5-HT in the ileum was detected by immunohistologic method.

Results: Cisplatin, apomorphine, copper sulfate and X-irradiation administered to minks evoked a profound emetic response in the animals. However, retching and vomiting were significantly inhibited by pretreatment with ondansetron and metoclopramide in cisplatin and copper sulfate groups (P=0.018). Immunohistologic result showed that 5-HT released from enterochromaffin cells (EC cells) was involved in vomiting mechanism.

Conclusion: Mink vomit model has a great value in studying the vomiting mechanism and screening new antiemetic drugs.

Citing Articles

Cisplatin-Induced Nausea and Vomiting: Effect of Herbal Medicines.

Shin Y, Kim B, Kim W Plants (Basel). 2022; 11(23).

PMID: 36501434 PMC: 9736559. DOI: 10.3390/plants11233395.


Appropriateness to set a group health based guidance value for nivalenol and its modified forms.

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B EFSA J. 2020; 15(4):e04751.

PMID: 32625457 PMC: 7009959. DOI: 10.2903/j.efsa.2017.4751.


Appropriateness to set a group health based guidance value for T2 and HT2 toxin and its modified forms.

Knutsen H, Barregard L, Bignami M, Bruschweiler B, Ceccatelli S, Cottrill B EFSA J. 2020; 15(1):e04655.

PMID: 32625252 PMC: 7010130. DOI: 10.2903/j.efsa.2017.4655.


Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems.

Tian L, Qian W, Qian Q, Zhang W, Cai X J Nat Med. 2019; 74(2):353-370.

PMID: 31768887 PMC: 7044144. DOI: 10.1007/s11418-019-01372-x.


Suppression of Cisplatin-Induced Vomiting by in Pigeons: Neurochemical Evidences.

Ullah I, Subhan F, Alam J, Shahid M, Ayaz M Front Pharmacol. 2018; 9:231.

PMID: 29615907 PMC: 5865282. DOI: 10.3389/fphar.2018.00231.


References
1.
Tsuchiya M, Fujiwara Y, Kanai Y, Mizutani M, Shimada K, Suga O . Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret. Pharmacology. 2002; 66(3):144-52. DOI: 10.1159/000063796. View

2.
Minami M, Endo T, Tamakai H, Ogawa T, Hamaue N, Hirafuji M . Antiemetic effects of N-3389, a newly synthesized 5-HT3 and 5-HT4 receptor antagonist, in ferrets. Eur J Pharmacol. 1997; 321(3):333-42. DOI: 10.1016/s0014-2999(96)00974-0. View

3.
Endo T, Minami M, Monma Y, Saito H, Takeuchi M . Emesis-related biochemical and histopathological changes induced by cisplatin in the ferret. J Toxicol Sci. 1990; 15(4):235-44. DOI: 10.2131/jts.15.235. View